STOCK TITAN

[Form 4] Henry Schein Inc Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Henry Schein director Daniel William K reported acquiring 10,000 shares of common stock on 08/07/2025 at a price of $67.08. After that reported purchase, the filing shows 10,000 shares beneficially owned indirectly through a trust for which the reporting person and spouse serve as co‑trustees.

The Form 4 also lists a disposition of 2,849 shares; the table does not provide a transaction date or a price for that disposition, so timing and proceeds are not specified in the filing.

Il direttore di Henry Schein Daniel William K ha dichiarato di aver acquisito 10,000 azioni ordinarie il 08/07/2025 al prezzo di $67.08. Dopo tale acquisto dichiarato, il documento indica che 10,000 azioni sono detenute indirettamente attraverso un trust per il quale il dichiarante e il coniuge fungono da co‑trustee.

Il Modulo 4 riporta inoltre una cessione di 2,849 azioni; la tabella non specifica la data della transazione né il prezzo per tale cessione, quindi tempistica e proventi non sono indicati nel deposito.

El director de Henry Schein, Daniel William K, informó la adquisición de 10,000 acciones ordinarias el 08/07/2025 a un precio de $67.08. Tras esa compra informada, la presentación muestra que 10,000 acciones son propiedad beneficiaria de forma indirecta a través de un fideicomiso en el que el informante y su cónyuge actúan como cotutores.

El Formulario 4 también incluye una enajenación de 2,849 acciones; la tabla no proporciona fecha ni precio de la transacción, por lo que la fecha y los ingresos no se especifican en la presentación.

Henry Schein의 이사 Daniel William K08/07/2025에 보통주 10,000주를 주당 $67.08에 취득했다고 보고했습니다. 해당 매입 후 제출서류에는 보고인과 배우자가 공동 수탁자로 있는 신탁을 통해 간접적으로 10,000주를 실질적으로 보유하고 있는 것으로 기재되어 있습니다.

해당 Form 4에는 또한 2,849주의 처분도 기재되어 있으나, 표에는 그 처분의 거래일자나 가격이 기재되어 있지 않아 시기와 처분대금은 제출서류에 명시되어 있지 않습니다.

Le directeur de Henry Schein, Daniel William K, a déclaré l'acquisition de 10,000 actions ordinaires le 08/07/2025 au prix de $67.08. Après cet achat déclaré, le dossier indique que 10,000 actions sont détenues de manière indirecte via une fiducie pour laquelle le déclarant et son conjoint exercent la fonction de co‑fiduciaires.

Le formulaire 4 mentionne également une cession de 2,849 actions ; le tableau ne précise ni la date ni le prix de cette transaction, de sorte que le calendrier et le produit ne sont pas indiqués dans le dépôt.

Der Direktor von Henry Schein, Daniel William K, meldete den Erwerb von 10,000 Stammaktien am 08/07/2025 zu einem Preis von $67.08. Nach diesem gemeldeten Kauf weist die Einreichung aus, dass 10,000 Aktien indirekt über einen Trust gehalten werden, für den die meldende Person und der Ehepartner als Co‑Treuhänder fungieren.

Das Formular 4 verzeichnet außerdem eine Veräußerung von 2,849 Aktien; die Tabelle nennt kein Transaktionsdatum und keinen Preis für diese Veräußerung, sodass Zeitpunkt und Erlös in der Einreichung nicht angegeben sind.

Positive
  • Reporting person acquired 10,000 shares at $67.08, a clear, explicit purchase disclosed on the Form 4
  • Post-transaction beneficial ownership of 10,000 shares is identified as held indirectly through a trust with the reporting person and spouse as co‑trustees
Negative
  • The filing lists a disposition of 2,849 shares but the table does not specify a transaction date or price for that sale, limiting transparency
  • Sale details (date/price) missing for the 2,849-share disposition, preventing clear assessment of net change in economic exposure

Insights

TL;DR: Director bought 10,000 HSIC shares at $67.08; a 2,849-share sale is reported but lacks date/price, so impact appears routine.

The filing documents a purchase of 10,000 shares at $67.08, resulting in 10,000 shares beneficially owned indirectly via a family trust. A separate disposition of 2,849 shares is reported without transaction date or price, which limits assessment of net share change and economic impact. Based solely on the disclosure, this appears to be routine insider activity rather than a materially transformative event.

TL;DR: Ownership held indirectly through a co‑trustee arrangement; disclosure is standard but missing sale details reduce transparency.

The report shows indirect beneficial ownership via a trust where the reporting person and spouse are co‑trustees, a common governance structure for insiders. The acquisition line clearly states purchase details, but the reported disposition of 2,849 shares lacks date and price in the table, which weakens the completeness of the disclosure. The Form otherwise follows standard Section 16 reporting format.

Il direttore di Henry Schein Daniel William K ha dichiarato di aver acquisito 10,000 azioni ordinarie il 08/07/2025 al prezzo di $67.08. Dopo tale acquisto dichiarato, il documento indica che 10,000 azioni sono detenute indirettamente attraverso un trust per il quale il dichiarante e il coniuge fungono da co‑trustee.

Il Modulo 4 riporta inoltre una cessione di 2,849 azioni; la tabella non specifica la data della transazione né il prezzo per tale cessione, quindi tempistica e proventi non sono indicati nel deposito.

El director de Henry Schein, Daniel William K, informó la adquisición de 10,000 acciones ordinarias el 08/07/2025 a un precio de $67.08. Tras esa compra informada, la presentación muestra que 10,000 acciones son propiedad beneficiaria de forma indirecta a través de un fideicomiso en el que el informante y su cónyuge actúan como cotutores.

El Formulario 4 también incluye una enajenación de 2,849 acciones; la tabla no proporciona fecha ni precio de la transacción, por lo que la fecha y los ingresos no se especifican en la presentación.

Henry Schein의 이사 Daniel William K08/07/2025에 보통주 10,000주를 주당 $67.08에 취득했다고 보고했습니다. 해당 매입 후 제출서류에는 보고인과 배우자가 공동 수탁자로 있는 신탁을 통해 간접적으로 10,000주를 실질적으로 보유하고 있는 것으로 기재되어 있습니다.

해당 Form 4에는 또한 2,849주의 처분도 기재되어 있으나, 표에는 그 처분의 거래일자나 가격이 기재되어 있지 않아 시기와 처분대금은 제출서류에 명시되어 있지 않습니다.

Le directeur de Henry Schein, Daniel William K, a déclaré l'acquisition de 10,000 actions ordinaires le 08/07/2025 au prix de $67.08. Après cet achat déclaré, le dossier indique que 10,000 actions sont détenues de manière indirecte via une fiducie pour laquelle le déclarant et son conjoint exercent la fonction de co‑fiduciaires.

Le formulaire 4 mentionne également une cession de 2,849 actions ; le tableau ne précise ni la date ni le prix de cette transaction, de sorte que le calendrier et le produit ne sont pas indiqués dans le dépôt.

Der Direktor von Henry Schein, Daniel William K, meldete den Erwerb von 10,000 Stammaktien am 08/07/2025 zu einem Preis von $67.08. Nach diesem gemeldeten Kauf weist die Einreichung aus, dass 10,000 Aktien indirekt über einen Trust gehalten werden, für den die meldende Person und der Ehepartner als Co‑Treuhänder fungieren.

Das Formular 4 verzeichnet außerdem eine Veräußerung von 2,849 Aktien; die Tabelle nennt kein Transaktionsdatum und keinen Preis für diese Veräußerung, sodass Zeitpunkt und Erlös in der Einreichung nicht angegeben sind.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DANIEL WILLIAM K

(Last) (First) (Middle)
C/O HENRY SCHEIN, INC.
135 DURYEA ROAD

(Street)
MELVILLE NY 11747

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HENRY SCHEIN INC [ HSIC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.01 per share 08/07/2025 P 10,000 A $67.08 10,000 I The Reporting Person and spouse as Co-Trustees of a trust for the benefit of the Reporting Person.
Common Stock, par value $0.01 per share 2,849 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Jennifer Ferrero (as attorney-in-fact for William K. Daniel) 08/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did HSIC report on this Form 4?

The Form 4 shows director Daniel William K purchased 10,000 shares at $67.08 on 08/07/2025 and separately reports a disposition of 2,849 shares (date and price for the sale are not specified).

How many HSIC shares does the reporting person beneficially own after the transaction?

The filing reports 10,000 shares beneficially owned following the reported purchase, held indirectly through a trust where the reporting person and spouse are co‑trustees.

Was the acquisition direct or indirect according to the Form 4?

Ownership is reported as indirect for the acquired shares, with the reporting person and spouse acting as co‑trustees of a trust that holds the shares.

Are there any derivative transactions reported for HSIC in this filing?

No. Table II for derivative securities contains no entries; the reported activity is limited to common stock transactions in Table I.

Does the Form 4 include the transaction date and price for the reported sale of 2,849 shares?

No. The form lists a disposition of 2,849 shares but the table does not provide a transaction date or a price for that disposition.
Henry Schein

NASDAQ:HSIC

HSIC Rankings

HSIC Latest News

HSIC Latest SEC Filings

HSIC Stock Data

8.04B
104.39M
0.84%
107.3%
5.73%
Medical Distribution
Wholesale-medical, Dental & Hospital Equipment & Supplies
Link
United States
MELVILLE